Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
5.09
-0.16 (-3.05%)
At close: Aug 13, 2025, 4:00 PM
5.12
+0.03 (0.59%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$585,006
Market Cap
397.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
REPL News
- 16 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit – REPL - GlobeNewsWire
- 18 hours ago - Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - GlobeNewsWire
- 4 days ago - REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm - PRNewsWire
- 6 days ago - Replimune Group: The Prospects For FDA Approval After Rejection - Seeking Alpha
- 7 days ago - Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 days ago - Why Is Replimune Stock Trading Lower On Monday? - Benzinga
- 12 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - GlobeNewsWire
- 15 days ago - REPL INVESTORS: Replimune Group, Inc. (NASDAQ:REPL) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses - GlobeNewsWire